[go: up one dir, main page]

GB1102762A - Phthalane, isochromane and isochromene derivatives - Google Patents

Phthalane, isochromane and isochromene derivatives

Info

Publication number
GB1102762A
GB1102762A GB1185565A GB1185565A GB1102762A GB 1102762 A GB1102762 A GB 1102762A GB 1185565 A GB1185565 A GB 1185565A GB 1185565 A GB1185565 A GB 1185565A GB 1102762 A GB1102762 A GB 1102762A
Authority
GB
United Kingdom
Prior art keywords
phenyl
group
reaction
alkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1185565A
Inventor
Povl Viggo Peterson
Jette Holmblad
Torben Huld
Niels Lassen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
Kefalas AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB1143702D priority Critical patent/GB1143702A/en
Priority to GB1143703D priority patent/GB1143703A/en
Priority to US440752A priority patent/US3446620A/en
Application filed by Kefalas AS filed Critical Kefalas AS
Priority to GB1185565A priority patent/GB1102762A/en
Priority to US540438A priority patent/US3467675A/en
Priority to FR52555A priority patent/FR1471362A/en
Priority to DE1543715A priority patent/DE1543715C3/en
Priority to DE1543714A priority patent/DE1543714C3/en
Priority to CH349866A priority patent/CH475232A/en
Priority to CH349366A priority patent/CH491102A/en
Priority to CH80570A priority patent/CH495976A/en
Priority to AT239766A priority patent/AT256837B/en
Priority to AT239666A priority patent/AT256836B/en
Priority to DK131266AA priority patent/DK112531B/en
Priority to DK130966AA priority patent/DK134415B/en
Priority to DK131166AA priority patent/DK114981B/en
Priority to BE677903D priority patent/BE677903A/xx
Priority to NO162148A priority patent/NO123675B/no
Priority to ES0324379A priority patent/ES324379A1/en
Priority to FI660706A priority patent/FI48731C/en
Priority to NO162175A priority patent/NO118709B/no
Priority to ES0324378A priority patent/ES324378A1/en
Priority to FI660705A priority patent/FI48730C/en
Priority to NL6603606A priority patent/NL6603606A/xx
Priority to BR177982/66A priority patent/BR6677982D0/en
Priority to BR177980/66A priority patent/BR6677980D0/en
Priority to SE03600/66A priority patent/SE326193B/xx
Priority to NL6603604A priority patent/NL6603604A/xx
Priority to BR177971/66A priority patent/BR6677971D0/en
Priority to BE678035D priority patent/BE678035A/xx
Priority to SE03601/66A priority patent/SE326194B/xx
Priority to NO162176A priority patent/NO118710B/no
Priority to NL6603603A priority patent/NL6603603A/xx
Priority to SE03652/66A priority patent/SE327141B/xx
Priority to DE1522449A priority patent/DE1522449C3/en
Priority to FR54185A priority patent/FR5873M/fr
Priority to FR65950A priority patent/FR1491370A/en
Priority to FR65949A priority patent/FR1491369A/en
Priority to DK446867A priority patent/DK135780B/en
Publication of GB1102762A publication Critical patent/GB1102762A/en
Priority to US759503A priority patent/US3578452A/en
Priority to NO498370A priority patent/NO134437C/no
Priority to MY19739A priority patent/MY7300009A/en
Priority to MY197310A priority patent/MY7300010A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention comprises compounds of formula <FORM:1102762/C2/1> wherein A is -CR1R2-, -CR1R2-CH2-, -CHR1-CHR2 or -CR1=CH-, wherein each or R1 and R2 is a hydrogen atom or a C1- 8 alkyl group, -NR3R4 is a mono-or di-C1- 8 alkylamino group or is the radical of a 5- or 6-ring membered heterocyclic amine, R5 is a hydrogen atom or a cyclohexyl, phenyl or thienyl group optionally substituted by a halogen atom or a C1- 8 alkyl, C1- 8 alkoxy or trihalomethyl group, "alkylene" is a C2- 8 alkylene group having at least two carbon atoms in the chain between the ring carbon atom and the nitrogen atom, and X is a hydrogen or halogen atom or a C1- 8 alkyl, C1- 8 alkoxy or trihalomethyl group, pharmaceutically acceptable acid addition salts thereof, and their preparation by (a) dehydration of a compound of formula <FORM:1102762/C2/2> wherein -NR3R4 is a dialkylamino group, the alkylene group has three carbon atoms in the linking chain, and the group A is saturated, followed if desired by N-demethylation by reaction with a compound of formula ClCOOR6, wherein R6 is a C1- 8 alkyl or benzyl group, to form the corresponding carbamate, followed by hydrolysis, (b) reaction of a compound of formula <FORM:1102762/C2/3> wherein the group A is saturated, with a compound of formula Hal-alkylene -NR3R4 or Hal-alkylene-Hal, in the presence of an alkali metal amide, alkyl or phenyl, followed in the latter case by reaction with an amine HNR3R4, or (c) where A is unsaturated, treatment of a saturated group A with N-bromo-succinimide and dehydrobrominating with an alkali metal alcoholate. 4 - Dimethylamino - 1 - phenyl - 1 - [2 - (2- hydroxy - 2 - propyl) - 5 - chloro - phenyl]-butanol-1 is prepared from 6-nitro-3,3-dimethyl-phthalide by treatment with stannous chloride, diazotization and reaction with cuprous chloride to form 6-chloro-3,3-dimethyl-phthalide, treating this with phenyl magnesium bromide to form o - benzoyl - p - chlorophenyl - dimethylcarbinol, and treating this with dimethylaminopropyl magnesium bromide. 1 - (Phenyl or o - tolyl) - 3,3 - di - (methyl or ethyl) phthalanes are prepared by reaction of 1-(phenyl or o-tolyl)-3,3-di-(methyl or ethyl)-phthalene with lithium aluminium hydride to form 3 - [2 - (a - hydroxy - 2 - methylbenzyl)-phenyl - pentanol - 3 or 2 - [2 - (a - hydroxybenzyl) phenyl-propanol-2, followed by treatment with glacial acetic acid and concentrated hydrochloric acid. 4 - Dimethylamino - 1 - [2 - (2 - hydroxy - 2-propyl) phenyl]-butanol-1 is prepared by reaction of 3,3-dimethylphthalide with dimethylaminopropylmagnesium bromide to form 1-(3-dimethylaminopropyl) - 3,3 - dimethyl - phthalane-1-ol, and treating this with lithium aluminium hydride. The compounds of the invention have anti-depressant activity and may be used in pharmaceutical compositions in combination with a carrier, for example in forms suitable for oral or parenteral administration.
GB1185565A 1965-03-18 1965-03-19 Phthalane, isochromane and isochromene derivatives Expired GB1102762A (en)

Priority Applications (43)

Application Number Priority Date Filing Date Title
GB1143702D GB1143702A (en) 1965-03-18
GB1143703D GB1143703A (en) 1965-03-18
US440752A US3446620A (en) 1965-03-18 1965-03-18 Process for developing diazotype materials
GB1185565A GB1102762A (en) 1965-03-19 1965-03-19 Phthalane, isochromane and isochromene derivatives
US540438A US3467675A (en) 1965-03-18 1966-03-03 Antidepressant basic derivatives of phthalanes,iso-chromanes and iso-chromenes
FR52555A FR1471362A (en) 1965-03-18 1966-03-08 Process and composition for the development of reproductions or copies by diazotype
DE1543714A DE1543714C3 (en) 1965-03-18 1966-03-09 Basically substituted phthalan compounds and process for their preparation
DE1543715A DE1543715C3 (en) 1965-03-18 1966-03-09 Basically substituted phthalene derivatives and their pharmacologically acceptable acid addition salts and processes for their preparation
CH349866A CH475232A (en) 1965-03-18 1966-03-11 Process for the preparation of aminoalkyl-substituted phthalans and isochromanes
CH349366A CH491102A (en) 1965-03-18 1966-03-11 Process for the preparation of basic derivatives of phthalans and isochromans
CH80570A CH495976A (en) 1965-03-18 1966-03-11 Derivs of phthalanes isochromanes and isochromenes for
AT239766A AT256837B (en) 1965-03-19 1966-03-14 Process for the preparation of new aminoalkyl-substituted phthalans and isochromanes
AT239666A AT256836B (en) 1965-03-19 1966-03-14 Process for the preparation of new aminoalkyl-substituted phthalans and isochromans
DK131266AA DK112531B (en) 1965-03-18 1966-03-15 Process for the preparation of basic substituted phthalanes or isochromanes or acid addition salts thereof.
DK130966AA DK134415B (en) 1965-03-18 1966-03-15 Method for producing a reproduction of an original on a two-component diazotype material.
DK131166AA DK114981B (en) 1965-03-18 1966-03-15 Process for the preparation of basic substituted phthalanes or isochromanes or acid addition salts thereof.
BE677903D BE677903A (en) 1965-03-18 1966-03-16
NO162148A NO123675B (en) 1965-03-18 1966-03-17
ES0324378A ES324378A1 (en) 1965-03-19 1966-03-18 A method for preparing basic derivatives of ftalanos and isocroman. (Machine-translation by Google Translate, not legally binding)
NO162176A NO118710B (en) 1965-03-18 1966-03-18
NO162175A NO118709B (en) 1965-03-18 1966-03-18
ES0324379A ES324379A1 (en) 1965-03-19 1966-03-18 A METHOD FOR THE PREPARATION OF BASIC DERIVATIVES OF PHTHALANES AND ISOCROMANS.
FI660705A FI48730C (en) 1965-03-18 1966-03-18 Process for the preparation of therapeutically useful 1-aminoalkyl-substituted phthalans and isochromanes and their acid addition salts.
NL6603606A NL6603606A (en) 1965-03-18 1966-03-18
BR177982/66A BR6677982D0 (en) 1965-03-18 1966-03-18 PROCESS FOR THE PREPARATION OF BASIC FTALAN AND ISO-CHROMANE DERIVATIVES
BR177980/66A BR6677980D0 (en) 1965-03-18 1966-03-18 PROCESS FOR THE PREPARATION OF AMINO-ALKYLSUBSTITUED FTALANES AND ISO-CHROMANS
SE03600/66A SE326193B (en) 1965-03-18 1966-03-18
NL6603604A NL6603604A (en) 1965-03-18 1966-03-18
BR177971/66A BR6677971D0 (en) 1965-03-18 1966-03-18 PROCESS TO REVEAL MATERIALS OF THE DIAZOIC TYPE AND COMPOSITION OF REVELATOR FOR THAT END
BE678035D BE678035A (en) 1965-03-18 1966-03-18
SE03601/66A SE326194B (en) 1965-03-18 1966-03-18
FI660706A FI48731C (en) 1965-03-18 1966-03-18 A process for the preparation of therapeutically useful 1-aminoalkyl-substituted phthalans and isochromanes and their acid addition salts.
NL6603603A NL6603603A (en) 1965-03-18 1966-03-18
SE03652/66A SE327141B (en) 1965-03-18 1966-03-18
DE1522449A DE1522449C3 (en) 1965-03-18 1966-03-18 Process for developing a two-part diazotype material
FR54185A FR5873M (en) 1965-03-18 1966-03-19
FR65950A FR1491370A (en) 1965-03-18 1966-06-17 Process for the preparation of basic derivatives of phthalans and isochromanes
FR65949A FR1491369A (en) 1965-03-18 1966-06-17 Process for the preparation of isochromanes and aminoalkyl-substituted phthalans
DK446867A DK135780B (en) 1965-03-18 1967-09-06 Develops to develop a latent image provided with a latent image diacotype material.
US759503A US3578452A (en) 1965-03-18 1968-09-12 Developing compositions for diazotype materials
NO498370A NO134437C (en) 1965-03-18 1970-12-30
MY19739A MY7300009A (en) 1965-03-18 1973-12-31 Diazotype delopment materials
MY197310A MY7300010A (en) 1965-03-18 1973-12-31 A process for developing diazotype materials

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1185565A GB1102762A (en) 1965-03-19 1965-03-19 Phthalane, isochromane and isochromene derivatives

Publications (1)

Publication Number Publication Date
GB1102762A true GB1102762A (en) 1968-02-07

Family

ID=9993930

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1185565A Expired GB1102762A (en) 1965-03-18 1965-03-19 Phthalane, isochromane and isochromene derivatives

Country Status (3)

Country Link
AT (2) AT256836B (en)
ES (2) ES324379A1 (en)
GB (1) GB1102762A (en)

Also Published As

Publication number Publication date
AT256836B (en) 1967-09-11
ES324379A1 (en) 1967-03-16
AT256837B (en) 1967-09-11
ES324378A1 (en) 1967-03-16

Similar Documents

Publication Publication Date Title
EP0144986A3 (en) Indole-3-carboxamide derivatives
GB1410511A (en) Thiazole cardiovascular agnets
ES8401067A1 (en) Treatment of migraine with tropyl benzoate derivatives.
DE3376421D1 (en) Analgesia-effecting 5-hydroxytryptophan derivatives
GB1086192A (en) Phenylcyclopropane derivatives
GB1062714A (en) -ß-(4&#39;-acyloxy-4&#39;-piperidyl)-ketones
GB1018773A (en) ª‡-phenyl-ª‰-2-furyl-propionitrile derivatives
EP0234173A3 (en) Phenoxy-substituted beta-carboline derivatives, their preparation and their use as medicaments
ES8500884A1 (en) Esters of aryloxypropanolamine derivatives and use as beta-adrenergic blocking agents.
GB1102762A (en) Phthalane, isochromane and isochromene derivatives
GB1169945A (en) Pharmaceutical Compositions containing Diphenylalkyl-amine Derivatives
GB1123768A (en) New thebaine and oripavine derivatives and processes for preparing the same
GB1038919A (en) Quinolizine derivatives and their preparation
US4143143A (en) Substituted imidazo[5,1-a]isoquinolines
GB1033920A (en) Novel derivatives of triphenylethanols
GB997637A (en) Substituted 2-cyclopropylmethyl-6,7-benzmorphans
ES8505653A1 (en) Treatment of migraine with N-alkyl-piperidinyl benzoate derivatives.
GB1249512A (en) 0,2,3,4-tetrahydro-7-halo-6-sulfamyl-4-quinazolinones, process for preparing the same and pharmaceutical compositions comprising the same
GB1342713A (en) Imidazole derivatives
US3823153A (en) 2-substituted-3a,4,5,6,7,7a-hexahydro-3a-hydroxybenzothiazolium halides
GB1095912A (en) Trans indolomorphinans and preparation thereof
GB1076966A (en) 2-aminoindane derivatives
ES369889A1 (en) Quinoxaline-1,4-dioxides
GB1108180A (en) New imidazole derivatives their production and use
ES443178A1 (en) Pyrazolodiazocine compounds